StockData
Boundless Bio, Inc. logo

Boundless Bio, Inc. (BOLD) stock

BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$2.40−0.01 (-0.41%)

Close on Nov 18, 2026Market cap $54.60MP/E –Yield –

Boundless Bio gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Boundless Bio

Boundless Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Boundless Bio figures

See a number that looks wrong?